PANews September 19 news, according to Crypto Briefing, the SEC has received a revised S-1/A registration statement for 21Shares’ Injective ETF. The filing updates the original document from October 2025. If approved, the ETF will be listed on Nasdaq under the TINJ ticker, passively tracking the performance of the INJ token through the FTSE Injective index, and may optionally pledge a portion of its holdings to enhance returns. 21Shares previously launched an Injective staking ETP in Europe, and this time it is expanding to the U.S. market.